Anaplastic Astrocytoma - Pharmaceuticals and Healthcare

Latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma  - Pipeline Review, H2 2017, provides an overview of the Anaplastic astrocytoma(Oncology) pipeline landscape.

Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic astrocytoma grows faster and more aggressively than grade II astrocytomas.

The tumor cells are not uniform in appearance and invade neighboring tissue. Symptoms include a headache, weakness, clumsiness, difficulty walking and seizures. Anaplastic astrocytoma is common among men and women in their thirties to fifties and is more common in men than women. Treatment of anaplastic astrocytoma depends on the location of the tumor and how far it has progressed and usually involves surgery and radiation therapy, with chemotherapy during or following radiation.



For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Anaplastic Thyroid Cancer - Pipeline Insight, 2017

Contact Details:
Aarkstore Enterprise
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242

Email: enquiry@aarkstore.com
Our website: http://www.aarkstore.com
Our blog: http://www.aarkstore.com/blog/







Comments

Popular posts from this blog

India travels across!

A detailed SWOT report on A.P. Moller – Maersk

Human Parainfluenza Virus 3 Infections, H1 2018